LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline.

Abhilasha SinghAshok Kumar SrinivasanLakshmi Narasimhan Chakrapani Periandavan Kalaiselvi

Published in: Oxidative medicine and cellular longevity (2019)

This study validates AG to be an effective stratagem in bringing down the lipid stress induced by HCD and can be deemed as an antihypercholesterolemic agent.

Keyphrases

quantum dots
cardiovascular events
low density lipoprotein
fatty acid
cardiovascular disease
type diabetes
highly efficient